Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Deal value drops by 34.2 per cent in April 2025, compared to April 2024
GlobalData reveals the pharma and healthcare industry reported 81 deals worth $9.6 billion and 85 venture capital deals worth $2…
FDA approves trial to advance treatment for Hereditary Spastic Paraplegia (HSP)
The trial will be conducted in the United States at Boston Children’s Hospital and will assess the safety, tolerability, and…
US subsidiary of Senores Pharma appoints Gautam Shah as President of US Operations
As President of US Operations, he will lead the entire group’s US operations and will be instrumental in future expansion
TPG acquires 35% stake in SCHOTT Poonawalla JV
Serum Institute of India will retain a minority stake in the company, with SCHOTT Pharma maintaining 50 per cent ownership
Roquette restructures company, appoints new leaders following the acquisition of IFF Pharma…
The company launches two new business groups and appoints new leaders
Three CAR-T therapies forecasted to capture over 70 per cent of T-Cell immunotherapy market in 2025
GlobalData’s latest report reveals that the TCI space is entering a new growth phase, driven by clinical success and investor…
Charting the global evolution of Indian pharma
The Ahmedabad Pharma Summit 2025 brought together policymakers, industry leaders, and innovators to explore pathways for global…
Panel Discussion: Leadership playbook for scaling pharma businesses
The final panel discussion of the day, titled ‘Leadership playbook for scaling pharma businesses,’ brought together a lineup of…
Quality management maturity as a driver for achieving pharmaceutical global excellence
Vipul Doshi, Chief Quality and Compliance Officer, Zydus Life Sciences delivered a session on "Quality Management Maturity (QMM):…
GLP-1R agonists can redefine chronic disease treatment beyond diabetes and obesity
GlobalData’s latest report showcases an analysis of the GLP-1R agonists pipeline in multiple indications, highlighting the areas…